Objective: To evaluate the long-term effects of percutaneous transluminal renal angioplasty (PTRA) on blood pressure and renal function in patients with fibromuscular dysplasia (FMD). Methods: Patients in whom FMD was diagnosed during renal angiography (n = 51) were compared with a matched group of hypertensive patients in whom angiography revealed normal renal arteries (n = 51). Blood pressure, intensity of antihypertensive medication and creatinine clearance were assessed at 0, 1, 6 and 12 months. In addition, we recorded the frequencies of cure, improvement and failure of treatment. Results: The two groups did not differ with regard to baseline characteristics. In the FMD group, average blood pressure fell from 172/97 to 155/90mmHg (
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
Background. The results of recent trials have brought some confusion to the treatment strategy for r...
Objective: To evaluate the long-term effects of percutaneous transluminal renal angioplasty (PTRA) o...
Objective: To evaluate the long-term effects of percutaneous transluminal renal angioplasty (PTRA) o...
AbstractObjectives: to assess restenosis rates and blood pressure response after percutaneous transl...
Fibromuscular dysplasia (FMD) mainly affects renal arteries. Percutaneous transluminal renal angiopl...
BackgroundPercutaneous intervention for symptomatic renal artery fibromuscular dysplasia (FMD) has r...
Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory vascular disease involving ...
Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory vascular disease involving ...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
AbstractObjectives: to assess restenosis rates and blood pressure response after percutaneous transl...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
Background. The results of recent trials have brought some confusion to the treatment strategy for r...
Objective: To evaluate the long-term effects of percutaneous transluminal renal angioplasty (PTRA) o...
Objective: To evaluate the long-term effects of percutaneous transluminal renal angioplasty (PTRA) o...
AbstractObjectives: to assess restenosis rates and blood pressure response after percutaneous transl...
Fibromuscular dysplasia (FMD) mainly affects renal arteries. Percutaneous transluminal renal angiopl...
BackgroundPercutaneous intervention for symptomatic renal artery fibromuscular dysplasia (FMD) has r...
Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory vascular disease involving ...
Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory vascular disease involving ...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
AbstractObjectives: to assess restenosis rates and blood pressure response after percutaneous transl...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
International audienceObjective: The indication of percutaneous renal transluminal angioplasty (PTRA...
Background. The results of recent trials have brought some confusion to the treatment strategy for r...